A phase I study of PXD101 (belinostat) in patients with unresectable hepatocellular carcinoma (HCC): a multicenter study by the Cancer Therapeutics Research Group (CTRG)
Refereed conference paper presented and published in conference proceedings
全文
沒有全文檔案提供 |
其它資訊
著者YEO Winnie, CHAN Lam Stephen, MO Kwok Fai, LIM R, MA Buig Yue Brigette, HUI Pun Edwin, YU S, KOH Chun, CHAN Anthony Tak Cheung, GOH B C
會議名稱19th Conference of the Asian Pacific Association for the Study of the Liver
會議開始日13.02.2009
會議國家/地區中國
會議論文集題名19th Conference of the Asian Pacific Association for the Study of the Liver
出版年份2009
月份2
日期13
出版地China, Hong Kong
頁次p158
語言英式英語
關鍵詞hepatocellular carcinoma; PXD101
